All news

Elite Wealth lifts Gilead stake 171.5% in third quarter

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Elite Wealth Management Inc. raised its Gilead Sciences stake by 171.5% in the third quarter, bringing holdings to 41,361 shares worth about $6.17 million. The move follows Gilead's third-quarter results, which beat analyst EPS and revenue estimates, plus favorable pipeline updates in HIV prevention and primary biliary cholangitis.

Read original source

GILD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.